Differentiation-dependent expression of human?-galactoside?2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells

This publication has 49 references indexed in Scilit:

• Resistance to Methotrexate Is Associated with Selective Changes of α2,6- and α2,3-Sialyltransferase Activities toward N-Acetyllactosaminic Sequences in Human Colon Cancer Cell Line HT-29
  Biochemical and Biophysical Research Communications, 1993
• Analysis of kidney mRNAs expressed from the rat β-galactoside α2,6-sialyltransferase gene
  Glycobiology, 1992
• The expression of soluble and cell-bound α2,6 sialyltransferase in human colonic carcinoma CaCo-2 cells correlates with the degree of enterocytic differentiation
  Biochemical and Biophysical Research Communications, 1992
• The c-Ha-ras oncogene induces increased expression of β-galactoside α-2,6-sialyltransferase in rat fibroblast (FR3T3) cells
  Glycobiology, 1992
• α2, 6 sialylation ofN-acetyllactosaminic sequences in human colorectal cancer cell lines. Relationship with non-adherent growth
  International Journal of Cancer, 1991
• Rat β-galactoside α2,6-sialyltransferase genomic organization: alternate promoters direct the synthesis of liver and kidney transcripts
  Glycobiology, 1990
• Sialic acid dependent cell adhesion to collagen IV correlates with in vivo tumorigenicity of the human colon carcinoma sublines HCT116, HCT116a and HCT116b
  Biochemical and Biophysical Research Communications, 1990
• The B cell antigen CD75 is a cell surface sialytransferase.
  The Journal of Experimental Medicine, 1990
• Prevalence of ras gene mutations in human colorectal cancers
  Nature, 1987
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
  Biochemistry, 1979